• Slide

    Lung Cancer Europe Roundtable 2017

    Tuesday 7th November 2017, Brussels

  • Slide

    Lung Cancer Europe Roundtable 2017

    Tuesday 7th November 2017, Brussels

  • Slide

    Lung Cancer Europe Roundtable 2017

    Tuesday 7th November 2017, Brussels

  • Slide

    Lung Cancer Europe Roundtable 2017

    Tuesday 7th November 2017, Brussels

  • Slide

    Lung Cancer Europe Roundtable 2017

    Tuesday 7th November 2017, Brussels

  • Slide

    Lung Cancer Europe Roundtable 2017

    Tuesday 7th November 2017, Brussels

  • Slide

    Lung Cancer Europe Roundtable 2017

    Tuesday 7th November 2017, Brussels

  • Slide

    Lung Cancer Europe Roundtable 2017

    Tuesday 7th November 2017, Brussels

  • Slide

    Lung Cancer Europe Roundtable 2017

    Tuesday 7th November 2017, Brussels

Lung cancer is the fourth most common cancer Europe, accounting for approximately 20% of total cancer deaths. It remains the leading cause of cancer deaths worldwide, with 376,000 deaths in 2012 in Europe alone. Incidence rates are highest in Hungary for men and in Denmark for women.

Despite recent advances in surgery, chemotherapy and radiotherapy, seven out of eight patients die within 5 years of diagnosis.

An extensive list of risk factors has been well characterised and lifestyle changes have occurred in order to combat lung cancer, but despite this, it remains a huge health problem.

Continued investment in research and innovation is essential for improving diagnostic accuracy and developing novel therapeutic approaches.

The EU must raise greater awareness of lung cancer through educating, highlighting the risk factors and symptoms and promoting healthier lifestyles as a preventive measure.

This roundtable meeting will bring together EU policy makers, medical and clinical professionals, academic experts, healthcare players and patient groups, to examine the ongoing challenges in managing lung cancer more effectively and explore practical solutions in order to reach an EU-wide consensus and implement a forward action plan.

At this roundtable, participants will hear from high level EU health officials and leading oncology experts, offering a variety of perspectives and recommendations through a series of open discussions.


Subjects to be addressed include:
  • Potential for a uniform EU-wide policy
  • Data and information sharing between member states
  • A patient-centred, multidisciplinary approach to lung cancer management
  • Accuracy of current diagnostic techniques
  • New developments and technology
  • Holistic personalised management to improve quality of life
  • Reaching an EU-wide consensus for improved diagnostic accuracy, effective Management and Care
  • Radiotherapy, chemotherapy, biological and targeted therapy
  • Surgical methods; Lobectomy, Pneumonectomy, Wedge resection or segmentectomy
Networking:

The Roundtable will also provide hours of networking time, including coffee breaks, lunch to ensure participants have the maximum possible time to establish and strengthen relationships, whilst exchanging ideas.